Therapeutic management of bone demineralization in the HIV-infected population
Eugènia Negredo(Universitat de Vic - Universitat Central de Catalunya), Bonaventura Clotet(Universitat de Vic - Universitat Central de Catalunya), Denise Cinquegrana(Johns Hopkins University), Carla Estany(Universitat Autònoma de Barcelona), Eva Martínez(Universitat Autònoma de Barcelona)
Cited by 8
Related Papers
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
|The Lancet Infectious Diseases|2011|172
Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2005|151
Factors Associated With Missed Appointments at an Academic Pain Treatment Center: A Prospective Year-Long Longitudinal Study
|Anesthesia & Analgesia|2017|73